Τόμος 8 (1994) – Τεύχος 1 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 8 (1994) – Issue 1 – Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Clinical and Molecular Neurogenetics Unit, Department of Neurology, Athens University

Accepted for publication: 2 December 1993

pharmakonpress[at]pharmakonpress[.]gr

2.    Giles, R.E., Blanc, H., Cann, H.M., Wallace, D.C.: Maternal inheritance of human mitochondrial DNA. Proc. Natl. Acad. Set. USA 77: 6715-6719 (1980)

3.    Oliver, N.A., Wallace, D.C.: Assignment of two mitochondrially synthesized polypeptides to human mtDNA and their use in the study of intracellular mitochondrial interaction. Mol. Cell Biol. 2: 33-41 (1982)

4.    Levings, C.S., Brown, G.G.: Molecular biology of plant mitochondria. Cell 56: 171-179 (1989)

5.    Anderson, S., Bankier, A.T., Barrel, B.G. et al: Sequence and organization of the human mitochondrial genome. Nature 290: 457-465 (1981)

6.    Zeviani, M., Bonilla, E., DeVivo, D.C., DiMauro, S.: Mitochondrial diseases. Neurologic Clinics Vol. 7, No1, pp. 123-156, 1989

7.    Wallace, D.C.: Mitotic segregation of mitochondrial DNAs in human cell hybrids and expression of chloramphenicol resistance. Somatic Cell Mol. Genet. 12: 41-49 (1986)

8.    Nohaka, I.: Mitochondrial diseases. Curr. Opin. Neurol. Neurosurg. 5: 622-632 (1992)

9.    DiMauro, S., Bonilla, E., Zeviani, M. et al: Mitochondrial myopathies. Ann. Neurol. 17: 521-529 (1985)

10.  Morgan-Hughes, J.A.:   The mitochondrial myopathies. In: Myology (Engel, A.G. and Banker, B.Q. eds), McGraw-Hill, New York, 1986

11.  Tritschler, H.J., Medori, R.: Mitochondrial DNA alterations as a source of human disorders. Neurology 46: 280-288 (1993)

12.  Harding, A.E., Petty, R.K.H., Morgan-Hughes, J.A.: The clinical features of mitochondrial myopathy. Brain 109: 915-938 (1986)

13.  Zeviani, M., Sakoda, S., Sherbany, A.A.: Sequence of cDNAs encoding subunits Vb of human and bovine cytochrome c oxidase. Gene 65: 1-12 (1988)

14.  Walser, M.: Urea cycle disorders and other hereditary hyperammonemic syndromes. In: The metabolic basis of inherited disease (Stanbury, J.B. et al. eds), Me Graw-Hill, New York, 1983

15.  Hirano, M., Ricci, E., Koenigsberger, M.R. et al: MELAS: An original case and clinical criteria for diagnosis. Neuromusc. Disord. 2: 125-135 (1992)

16.  Goto, Y.-l., Nonaka, I., Horai, S.A.: A mutation in the tRNALeu (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 346: 651-653 (1990)

17.  Ciafaloni, E., Ricci, E., Shanske, S. et al: MELAS: clinical features, biochemistry, and molecular genetics. Ann. Neurol. 31: 391-398 (1992)

18.  Goto, Y.-L, Nonaka, L, Horai, S.A.: A new mtDNA mutation associated with MELAS syndrome Biochim. Biophys. Acta 1097: 238-240 (1991)

19.  Berkovic, S.F., So, N.K., Andermann, F.: Progressive myoclonus epilepsies: clinical and neurophysiological diagnosis. J. Clin. Neurophysiol. 8: 261-274 (1991)

20.  Franceschetti, S., Antozzi, C., Binelli, S. et al: Progressive myoclonus epilepsies: an electroclinical, biochemical, morphological and molecular genetic study of 17 cases. Acta Neurol. Scand. 87: 219-223 (1993)

21.  Zeviani, M., Amati, P., Bresolin, M. et al: Rapid detection of the A-to-G (8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged-red fibres (MERRF). Am. J. Hum. Genet. 46: 203-211 (1991)

22.  Wallace, D.C., Singh, G., Lott, M.T. et al: Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological and biochemical characterization of a mitochondrial DNA disease. Cell 55: 601-610 (1988)

23.  Roger, J., Bureau, M., Dravet, C. et al: La place encephalopathies mitochondriales dans les epilepsies-myoclonies progressives. Rev. Neurol. 147: 480-490 (1991)

24.  Tsairts, P., Engel, W.K., Kark, P.: Familial myoclonic epilepsy syndrome associated with skeletal muscle mitochondrial abnormalities. Neurology 23: 408-415 (1973)

25.  Fukuhara, N., Tokiguchi, S., Shirakawa, K., Tsubaki, T.: Myoclonus epilepsy associated with ragged-red fibres: disease entity or a syndrome? J. Neurol. Sci. 47: 117-133 (1980)

26.  Johnson, M.A., Turnbull, D.M., Dick, D.J. et al: A partial deficiency of cytochrome c oxidase in chronic progressive external ophthalmoplegia. J. Neurol. Sci. 60: 3153-3162 (1983)

27.  Byrne, E., Dennet, X., Trounce, I. et al: Partial cytochrome oxidase (aa3) deficiency in chronic progressive external ophthalmoplegia. J. Neurol. Sci. 71: 257-263 (1985)

28.  Holt, I.J., Harding, A.E., Cooper, J.M.: Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann. Neurol. 26: 699-708 (1989)

29.  Zeviani, M., Moraes, C.T., Di Mauro, S. et al: Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 38: 1339-1346 (1988)

30.  Shoubridge, E.A., Karpati, G., Hastings, K.E.M.: Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial diseases. Cell 62: 43-49 (1990)

31.  Went, L.N.: Optic Atrophy. In: Principles and Practice of Medical Genetics (Emery, A.E.H. and Rimoin, D. eds), 2^nd edit, Churchill-Livingstone, Edinburgh, 1990

32.  Carroll, W.M., Mastaglia, F.L.: Leber’s optic neuropathy. A clinical and visual evoked potential study of affected and asymptomatic members of a six generation family. Brain 102: 559-580 (1979)

33.  Weerdt, C.J. de, Went, L.N.: Neurological studies families with Leber’s optic atrophy. Acta Neurol. Scand. 47: 541-544 (1971)

34.  Wallace, D.C., Singh, G., Lott, M.T. et al: Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 242: 1427-1430 (1988)

35.  Singh, G., Lott, M.T., Wallace, D.C.: A mitochondrial DNA mutation as a cause of Leber’s hereditary optic neuropathy, N. Engl. J. Med. 320: 1300-1305 (1989)

36.  Howell, N., Kubacka, I., Xu, M., McDullough, D.A.: Leber hereditary optic neuropathy: involvement of the mitochondrial ND-1 gene and evidence for an intragenetic suppressor mutation. Am. J. Hum. Genet. 43: 935-942 (1991)

37.  Schapira, A.H.V.: Mitochondrial myopathies. Brit. Med. J. 298: 1127-1128 (1989)

38.  Clay, V.J., Ragan, C.I.: Evidence for the existence of tissue specific isoenzymes of mitochondrial NADH dehydrogenase. Biochem. Biophys. Res. Commun. 157: 1423-1428 (1988)

39.  Holt, (J., Harding, A.E., Morgan-Hughes, J.A.: Deletions of mitochondrial DNA in patients with mitochondrial myopathy. Nature 331: 717-719 (1988)

40.  Schapira, A.H.V., Cooper, J.M., Morgan- Hughes, J.A. et al: Molecular basis of mitochondrial myopathies: polypeptide analysis in complex I deficiency, Lancet i: 500-503 (1988)

pharmakonpress[at]pharmakonpress[.]gr